Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2640347015 | Bismuth biskalcitrate 140mg/metornidazole 125mg/tetracycline 125mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2644402012 | Bismuth biskalcitrate 140mg/metornidazole 125mg/tetracycline 125mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2660741012 | Bismuth biskalcitrate 140mg/metronidazole 125mg/tetracycline 125mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2673329019 | Bismuth biskalcitrate 140mg/metronidazole 125mg/tetracycline 125mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3487329019 | Product containing bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3495685015 | Product containing bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3495686019 | Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570480018 | Product containing only bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570481019 | Product containing only bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677095011 | Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677096012 | Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677097015 | Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3122321000052116 | vismutbiskalcitrat 140 mg + metronidazol 125 mg + tetracyklin 125 mg, kapsel | sv | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| 4566331000052118 | metronidazol 125 milligram, tetracyklin 125 milligram och vismutbiskalcitrat 140 milligram, oral kapsel | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Bismuth biskalcitrate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Tetracycline (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Metronidazole (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Metronidazole-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | 125 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | 125 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har nämnarvärde som visar styrka | 1 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Tetracycline (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | 125 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Bismuth biskalcitrate (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | 140 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Metronidazole (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Metronidazole (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Metronidazole (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Bismuth biskalcitrate (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Bismuth biskalcitrate (substance) | true | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | 140 (qualifier value) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Tetracycline (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Tetracycline (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Tetracycline (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Metronidazole (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Bismuth biskalcitrate (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | räkning av bas i aktiv ingrediens | 3 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Metronidazole (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Bismuth biskalcitrate (substance) | true | Inferred relationship | Some | 3 | |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Tetracycline (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR